Skip to main content

Table 4 Influence of illness perception on RA disease activity, pain and fatigue over 12 months

From: Baseline predictors of remission, pain and fatigue in rheumatoid arthritis: the TITRATE trial

 

Crude

Adjusteda

β (95%CI)

p value

β (95%CI)

p value

Average scores (0, 6 and 12 months)

 DAS28-ESR

0.01 (−0.001, 0.02)

0.088

0.007 (−0.01, 0.02)

0.306

 Pain

0.73 (0.50, 0.96)

<0.001

0.62 (0.36, 0.88)

<0.001

 Fatigue

0.96 (0.68, 1.24)

<0.001

0.51 (0.20, 0.82)

0.001

12-month outcomes

 

Crude

Odds ratio (95%CI)

p value

Adjusteda

Odds ratio (95%CI)

p value

 Remission DAS28-ESR (<2.6)

1.00 (0.97, 1.03)

0.969

1.01 (0.96, 1.03)

0.808

 Change in pain (≥10 units)

1.01 (0.98, 1.03)

0.667

1.00 (0.98, 1.02)

0.642

 Change in fatigue (≥10 units)

1.01 (0.99, 1.04)

0.353

1.02 (0.98, 1.04)

0.387

  1. aAdjustment for age, gender, ethnicity, disease duration, NHS region and trial arm